Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.29 Delayed Data As of 4:00pm ET |  +0.07 / +3.15%Today’s Change | 0.82 Today|||52-Week Range 4.78 | -40.21% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 2.22 |
| Today’s open | 2.23 |
| Day’s range | 2.22 - 2.36 |
| Volume | 329,287 |
| Average volume (3 months) | 469,824 |
| Market cap | $93.8M |
Data as of 4:00pm ET, 12/06/2019
Growth & Valuation
| Earnings growth (last year) | +22.17% |
| Earnings growth (this year) | -65.79% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -44.44% |
| P/E ratio | NM |
| Price/Sales | 35.63 |
| Price/Book | 1.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SESNSesen Bio Inc | -0.02 | -1.67% |
| FENCFennec Pharmaceutica... | +0.07 | +1.05% |
| --Ecogreen Internation... | 0.00 | 0.00% |
| AVEOAveo Pharmaceuticals... | -0.01 | -1.18% |
Data as of 4:00pm ET, 12/06/2019
Financials
| Next reporting date | March 9, 2020 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $5.9M |
| Annual profit (last year) | -$57.1M |
| Net profit margin | -959.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Burnaby, British Columbia |
Forecasts
